glp-1 drug exposure pharmaceutical companies 2025 Receptor Agonist Market Size and Share Market Overview: GLP-1 Agonists and
Description
Easy-to-use patches to help you feel supported as you lose weight
Clinically, this is known as telogen effluvium and has been seen in some GLP-1 patients
However, regulatory uncertainties (pharma import tariffs, FDA scrutiny) mean many established biologics are still made in the US/EU companies favored sites ( [49] )
[Source: Fierce Pharma ] February 2025 Eli Lilly committed another $5.3 billion toward a manufacturing hub in Indiana to meet explosive demand for Mounjaro and Zepbound
Hair regrowth typically begins within three to six months of the shedding phase peaking
